Unexpected Pharmacokinetics of Vancomycin in Patients With Severe Acute Pancreatitis Compared With Pneumonia

The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome

NCT03452189 ·Status: COMPLETED ·Phase: PHASE2

Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics

NCT02212392 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin

NCT06234046 ·Status: COMPLETED ·Phase: PHASE3

Identification of Ascitic Fluid Bacterial Pathogens in Spontaneous Bacterial Peritonitis

NCT02463721 ·Status: UNKNOWN ·Phase: NA

Duration of Perioperative Antibiotics in Pancreatoduodenectomy

NCT07043855 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Multi-center Clinical Study of Drug Antibody and Precision Transfusion in China

NCT05606302 ·Status: UNKNOWN

Study Evaluating the Etiology of Intra-Abdominal Infections

NCT00244088 ·Status: COMPLETED

Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection

NCT02000414 ·Status: COMPLETED ·Phase: NA

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

NCT05302531 ·Status: RECRUITING ·Phase: PHASE1

A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

NCT00952796 ·Status: COMPLETED ·Phase: PHASE4

Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis

NCT03695705 ·Status: COMPLETED ·Phase: PHASE3

EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.

NCT05148702 ·Status: RECRUITING ·Phase: PHASE3

ORal Antibiotics in Acute Mesenteric Ischemia

NCT06387147 ·Status: RECRUITING ·Phase: PHASE3

Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections

NCT00752219 ·Status: COMPLETED ·Phase: PHASE2

Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

NCT02364284 ·Status: COMPLETED

Rifaximin Predicts the Complications of Decompensated Cirrhosis

NCT02074280 ·Status: UNKNOWN ·Phase: PHASE4

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections

NCT01445678 ·Status: COMPLETED ·Phase: PHASE3

Beta-lactam Pharmacokinetics in Patients With Infective Endocarditis

NCT02033421 ·Status: UNKNOWN

Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis

NCT04159870 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

NCT00481702 ·Status: COMPLETED ·Phase: PHASE3

Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections

NCT01155739 ·Status: COMPLETED

Peritoneal Diffusion and Efficacy of Antibiotic Therapy in Pediatric Peritonitis

NCT05308849 ·Status: UNKNOWN ·Phase: NA

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

NCT02387203 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Epidemiology of Infection With Vancomycin-Resistant Enterococci

NCT00018434 ·Status: COMPLETED

WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics

NCT01587768 ·Status: COMPLETED